Exploring research participation among cancer patients: analysis of a national survey and an in-depth interview study
暂无分享,去创建一个
H. Ward | S. Day | Helen Ward | Louise Mc Grath-Lone | C. Schoenborn | L. Mc Grath-Lone | Sophie Day | Claudia Schoenborn
[1] B. Thiers. Generalizability of Cancer Clinical Trial Results: Prognostic Differences between Participants and NonparticipantsElting LS, Cooksley C, Bekele BN, et al (Univ of Texas, Houston) Cancer 106:2452–2458, 2006§ , 2007 .
[2] Joy H. Lewis,et al. Participation of patients 65 years of age or older in cancer clinical trials. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[3] C. McDaid,et al. Systematic review of barriers, modifiers and benefits involved in participation in cancer clinical trials , 2006 .
[4] B Nebiyou Bekele,et al. Generalizability of cancer clinical trial results , 2006, Cancer.
[5] D. Kashy,et al. Attitudinal barriers to participation in oncology clinical trials: factor analysis and correlates of barriers. , 2015, European journal of cancer care.
[6] M Egger,et al. The causes and effects of socio-demographic exclusions from clinical trials. , 2005, Health technology assessment.
[7] Harlan M Krumholz,et al. Participation in cancer clinical trials: race-, sex-, and age-based disparities. , 2004, JAMA.
[8] M. Hansson,et al. Hope for a cure and altruism are the main motives behind participation in phase 3 clinical cancer trials. , 2015, European journal of cancer care.
[9] Z. Hall. Cancer , 1906, The Hospital.
[10] A. Hart,et al. Effects of patient selection on the applicability of results from a randomised clinical trial (EORTC 10853) investigating breast-conserving therapy for DCIS , 2002, British Journal of Cancer.
[11] L. Fallowfield,et al. Clinicians’ attitudes towards clinical trials of cancer therapy , 2011, British Journal of Cancer.
[12] Shari Bolen,et al. Provider roles in the recruitment of underrepresented populations to cancer clinical trials , 2007, Cancer.
[13] J. Donovan,et al. Capturing users' experiences of participating in cancer trials. , 2002, European journal of cancer care.
[14] A. Hart,et al. The impact of the physician on the accrual to randomized clinical trials in patients with primary operable breast cancer. , 2005, Breast.
[15] P M Ellis,et al. Attitudes towards and participation in randomised clinical trials in oncology: a review of the literature. , 2000, Annals of oncology : official journal of the European Society for Medical Oncology.
[16] Louette R. Johnson Lutjens. Research , 2006 .
[17] J. Crawford,et al. Survey of oncologists' perceptions of barriers to accrual of older patients with breast carcinoma to clinical trials , 2002, Cancer.
[18] J. Hardy,et al. Randomised controlled trials of palliative care - a survey of the views of advanced cancer patients and their relatives. , 2008, European journal of cancer.
[19] M. Hussain-Gambles,et al. Involving South Asian patients in clinical trials. , 2004, Health technology assessment.
[20] R. Jagsi,et al. Under‐representation of women in high‐impact published clinical cancer research , 2009, Cancer.
[21] S. Goodman,et al. Purpose and Benefits of Early Phase Cancer Trials: What Do Oncologists Say? What Do Patients Hear? , 2008, Journal of empirical research on human research ethics : JERHRE.
[22] M. Christian,et al. How sociodemographics, presence of oncology specialists, and hospital cancer programs affect accrual to cancer treatment trials. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[23] R. Prescott,et al. Factors that limit the quality, number and progress of randomised controlled trials. , 1999, Health technology assessment.
[24] D. Rubio,et al. Defining Translational Research: Implications for Training , 2010, Academic medicine : journal of the Association of American Medical Colleges.
[25] P Wainwright,et al. Virtual outreach: a randomised controlled trial and economic evaluation of joint teleconferenced medical consultations. , 2004, Health technology assessment.
[26] S. Moore. A need to try everything: patient participation in phase I trials. , 2001, Journal of advanced nursing.
[27] C. Coltman,et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. , 1999, The New England journal of medicine.
[28] A. Gafni,et al. Why cancer patients enter randomized clinical trials: exploring the factors that influence their decision. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[29] D. Farewell,et al. Drivers and barriers to patient participation in RCTs , 2013, British Journal of Cancer.
[30] E. Cook,et al. Comparison of outcomes in cancer patients treated within and outside clinical trials: conceptual framework and structured review , 2004, The Lancet.